Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers - ADME

Study identifier:D9830C00006

ClinicalTrials.gov identifier:NCT01058447

EudraCT identifier:2009-017478-19

CTIS identifier:N/A

Study Complete

Official Title

An Open, Single-Dose, Single-Centre, Phase I Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD1981

Sex

Male

Actual Enrollment

Study type

Interventional

Age

50 Years - 65 Years

Date

Study Start Date: 01 Feb 2010

Primary Completion Date: 01 Mar 2010

Study Completion Date: 01 Mar 2010

Study design

Allocation: N/A
Endpoint Classification: Bio-availability Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Apr 2025 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Experimental: 1	Drug: AZD1981 Oral tablet, 250 mg, single dose

"There is no result for the study"

Documents available

CSR-D9830C00006.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

Quintiles London

+ 44 0800 634 1132

Investigators

Principal Investigator

Eva S Pettersson

AstraZeneca R&D, Lund, Sweden